Ouro Foods
Develops biofabricated plant- and cell-based proteins using advanced 4D tissue engineering and bioprinting technologies for customizable food for health applications.
- CEO / Founder
- Elizabeth Bennett
- Team Size
- 1-10
- Stage
- Active
- Total Funding
- $1.45M
- Latest Round
- Acquired by Gilead Sciences for $2.18B
- Key Investors
- Gilead Sciences
Technology & Products
Key Products
Taste+
Technological Advantage
30x faster production scaling than current alt-protein technologies; nanoscale resolution (50nm) for precise texture control.
Differentiation
Value Proposition
Enables rapid production (under 1 minute) of 1cm³ food structures at 50nm resolution, allowing for customizable nutrition and texture for taste-impaired patients.
How They Differentiate
Utilizes non-extrusion bioprinting for 30x faster scaling and 50nm resolution compared to standard industry methods.
Market & Competition
Target Customers
Health-impaired individuals, specifically chemotherapy patients with taste impairment.
Industry Verticals
Food; Health; Nutrition
Competitors
Mooji Meats; Steakholder Foods; Revo Foods
Growth & Milestones
Growth Metrics
30x faster production/scaling than current alt-protein tech; 1cm³ structures produced in <1 min; 50nm resolution.
Major Milestones
Launch of Taste+ plant-based phase; Targeting hybrid plant/cell-based protein by 2026